 |
|
|
| |
Safety and Antiviral Effect of MK-1439, a Novel NNRTI, (+Truvada®)
in ART-Naive HIV Infected Patients
|
| |
| |
Reported by Jules Levin
CROI 2014 March 3-6 Boston, MA
J. O. Morales-Ramirez1, J. M. Gatell2, D. P. Hagins3,
M. Thompson4, K. Arasteh5, C. Hoffmann6, C. Harvey7,
X. Xu7, H. Teppler7 for the P007 Study Team
1Clinical Research Puerto Rico, San Juan, PR; 2Hospital Clinic/IDIBAPS. Univ of Barcelona, Spain; 3Chatham County Health Dept, Savannah, GA, USA; 4AIDS Research Consortium of Atlanta, GA, USA; 5EPIMED/Vivantes Auguste-Viktoria-Klinikum, Berlin, Germany; 6ICH Study Center, Hamburg, Germany; 7Merck & Co., Inc., Whitehouse Station, NJ, USA
CROI webcast:
http://www.croiwebcasts.org/console/player/22172?mediaType=slideVideo&
|
| |
|
|
|
|
|
